-
公开(公告)号:AT117996T
公开(公告)日:1995-02-15
申请号:AT88710048
申请日:1988-11-22
Applicant: HOECHST AG
Inventor: DE MEIJERE ARMIN PROF DR , DUEBAL HANS-ROLF DR , ESCHER CLAUS DR , HEMMERLING WOLFGANG DR , MUELLER INGRID DR , OHLENDORF DIETER DR , WINGEN RAINER DR
IPC: C07D20060101 , C07D213/30 , C07D237/08 , C07D237/10 , C07D237/14 , C07D239/26 , C07D239/32 , C07D239/34 , C07D239/38 , C07D241/12 , C07D285/12 , C07D303/48 , C07D317/10 , C07D405/12 , C09K19/34 , C09K19/42 , C09K19/46 , G02F1/13 , G02F1/137 , G02F1/141
Abstract: The liquid crystalline cyclopropylalkyl or -alkenyl heterocycles have the formula in which the symbols A , A , A are aromatic or heteroaromatic molecular building blocks, such as 1,4-phenylene or pyrimidin-2,5-diyl which are linked via a single bond (if k,m are zero) or via functional groups M , M , such as CO-O or CH2-O; j, k, l, m, n are zero or 1 (j+l+n = 2 or 3). The radicals R , R , R are H or alkyl/alkenyl, R is alkyl/alkenyl or one of the substituents known from LC chemistry, such as an alpha -haloalkanoic radical. In addition, at least one of the building blocks A , A , A must be heteroaromatic and G denotes alkylene or alkenylene.
-
公开(公告)号:DE3887048D1
公开(公告)日:1994-02-24
申请号:DE3887048
申请日:1988-09-14
Applicant: HOECHST AG
Inventor: DUEBAL HANS-ROLF DR , ESCHER CLAUS DR , HEMMERLING WOLFGANG DR , MUELLER INGRID DR , OHLENDORF DIETER DR , WINGEN RAINER DR
Abstract: The novel liquid-crystalline mixtures (in the case of ferroelectric behavior they additionally contain an optically active compound as dope) are constructed from at least 2 mixture components of the general formula (I): (I) wherein n=6 to 14 and x=2 to 14. In addition, the mixtures may also contain cyclohexanecarboxylates of the general formula (II) (II) where R1=(C10-C16) or (C8-C14)alkoxy and R2=(C2-C9)alkyl, alkenyloxyphenylpyrimidine derivatives of the general formula (III) (III) where R3=(C7-C16)alkyl or (C6-C14)alkoxy and y=4-14, and/or alkoxyphenyl derivatives of alkylpyrimidine, of the general formula (IV) (IV) where m and p=6 to 14.
-
公开(公告)号:DE58906564D1
公开(公告)日:1994-02-10
申请号:DE58906564
申请日:1989-09-19
Applicant: HOECHST AG
Inventor: HEMMERLING WOLFGANG DR , MUELLER INGRID DR , DUEBAL HANS-ROLF DR , ESCHER CLAUS DR , ILLIAN GERHARD DR , MURAKAMI MIKIO , OHLENDORF DIETER DR , WINGEN RAINER DR
IPC: C07D303/48 , C07D317/32 , C07D317/34 , C07D317/72 , C07D405/12 , C07D405/14 , C07D407/12 , C07D407/14 , C07D409/12 , C07D409/14 , C07D417/12 , C07D417/14 , C09K19/34 , C09K19/58
Abstract: Optically active 1,3-dioxolane-4-carboxylic acid esters and oxirane-2-carboxylic acid esters of the general formula (I) where R is, for example, C1-C16-alkyl or C1-C16-alkoxy, A , A and A are, for example, phenyl or pyrimidine-2,5-diyl, M and M are, for example, CO-O or CH2-CH2, j and l are 0, 1 or 2, k and m are 0 or 1, n is 0, 1 or 2, X is O or S and Ac is or where R , R , R , R and R are, for example, H or methyl, are particularly suitable doping agents for liquid-crystalline mixtures since they induce a high spontaneous polarisation and considerably reduce the melting point.
-
公开(公告)号:DE3886087D1
公开(公告)日:1994-01-20
申请号:DE3886087
申请日:1988-04-02
Applicant: HOECHST AG
Inventor: BAHR CHRISTIAN , HEPPKE GERD PROF DR , LOETZSCH DETLEF , DUEBAL HANS-ROLF DR , ESCHER CLAUS DR , OHLENDORF DIETER DR
IPC: C09K19/02 , C07D303/48 , C07D405/12 , C09K19/58 , G02F1/137 , G02F1/139 , G02F1/141 , G02F1/361 , G02F1/37
Abstract: Compounds which have a chiral, orthogonal, higher-order smectic phase, in particular a S B or a S E phase can be used in the region of this phase or phases as a display or switching medium in electro- optical display elements or switching elements which are based on the utilisation of the electrokinetic effect.
-
公开(公告)号:DE3883090D1
公开(公告)日:1993-09-16
申请号:DE3883090
申请日:1988-03-22
Applicant: HOECHST AG
Inventor: MUELLER INGRID DR , DUEBAL HANS-ROLF DR , ESCHER CLAUS DR , HEMMERLING WOLFGANG DR , OHLENDORF DIETER DR , WINGEN RAINER DR
IPC: G02F1/137 , C07D239/26 , C07D239/34 , C07D239/38 , C09K19/34 , G02F1/141
Abstract: New 3-phenylpyrimidines are of formula (I). In (I), R1 and R2 independently = linear or branched alk(en)yl with k to 16 C atoms, with or without asymmetrical C atoms, in which one or more nonadjacent CH2 gps. can be replaced by -O- or -S-; A and B independently = gps. of formula (a) or (b); R1, 2 = R1 or R2; m and n = 0 or 1 but m and n not both = 1; provided that: a) if m = 0, k = 8 and the CH2 gp. in R2 next to the phenyl ring is replaced by -O-; b) if m = 1 and n = 0, k = 2; and c) is m = 0 and n = 1, k = 2 and the CH2 gp. in R2 next to the phenyl ring is replaced by -O-. The prepn. of (I) is also claimed. 29 cpds. are claimed, including (S)-2-heptylthio-5- (4-(6-methyloctyloxy) phenol-pyrimidine (IA).
-
公开(公告)号:DE4127287A1
公开(公告)日:1993-02-18
申请号:DE4127287
申请日:1991-08-17
Applicant: HOECHST AG
Inventor: ESCHER CLAUS DR , ROESCH NORBERT DR
Abstract: The invention calls for cyclic compounds with 12 or more ring members, cryptands, coronands, podands, ionophoric compounds and polymers which include rings, where the rings may contain hetero-atoms, to be used in FLC displays in order to reduce optical hysteresis.
-
公开(公告)号:DE4111461A1
公开(公告)日:1992-10-15
申请号:DE4111461
申请日:1991-04-09
Applicant: HOECHST AG
Inventor: SCHLOSSER HUBERT DR , WINGEN RAINER DR , ILLIAN GERD DR , ESCHER CLAUS DR
IPC: C07D213/61 , C07D213/64 , C07D213/65 , C07D401/14 , C07D405/04 , C07D405/12 , C07F5/02 , C07F7/08 , C09K19/34 , C09K19/40
Abstract: New 2-fluoropyridine derivs. (I) are of formula (I), where R1-2 independently = H, F, Cl, CN, NCS, -CF3, -OCF3, -OCHF2 or linear or branched 1-16C alkyl (with or without asymmetrical C atom), in which one or two non-adjacent -CH2- gps. may be replaced by -O-, -S-, -CO-, -CO-O-, -O-CO-, -CO-S-, -S-CO-, -O-CO-O-, -CH=CH-, -C=C- or -Si(CH3)2- and also one or more H atoms of the alkyl gp. may be replaced by F, Cl, Br or CN; or a chiral gp. of the formulae (C1 to (C14) (where X = F or Cl; Y = -CO- or -CH2-; A1-4 independently = 1,4-phenylene, pyrazin-2,5-diyl, pyridazin-3,6-diyl, pyridin-2,5-diyl, pyrimidin-2,5-diyl (in which one or two H atoms may be replaced by F), trans-1,4-cyclohexylene (in which one or two H atoms may be replaced by CN), 1,3,4-thiadiazol-2,5-diyl, 1,3-dioxan-2,5-diyl, naphthalene-2,6-diyl, bicyclo(2.2.2)-octan-1,4-diyl or 1,3-dioxaborinan-2,5-diyl; M1-4 independently = -O-, -S-, -CO-, -CO-O-, -O-CO-, -CO-S-, -S-CO-, -O-CO-O-, -CH2-O-, -O-CH2-, -CH2-CH2-, -CH=CH- or -C=C-; R3-4 and R6-7 independently = H or linear or branched 1-16C alkl; or R3+R4 may also = -(CH2)4- or -CH2)5- if attached to a dioxolane system; M5 = -CH2-O-, -CO-O-, -O-CH2-, -O-CO- or a single bond; k, l, m, n, o, p, q and r = 0 or 1, such that (k+m+p+r) = less than 4 and more than 0.
-
公开(公告)号:DE4017893A1
公开(公告)日:1991-12-05
申请号:DE4017893
申请日:1990-06-02
Applicant: HOECHST AG
Inventor: ESCHER CLAUS DR , HARADA TAKAMASA , JAHN HELMUT , WEIPPERT ANDREAS
-
公开(公告)号:DE3915804A1
公开(公告)日:1990-11-15
申请号:DE3915804
申请日:1989-05-13
Applicant: HOECHST AG
Inventor: MEIJERE ARMIN DE PROF DR , DUEBAL HANS-ROLF DR , ESCHER CLAUS DR , HARADA TAKAMARA , HEMMERLING WOLFGANG DR , ILLIAN GERHARD DR , MUELLER INGRID DR , MURAKAMI MIKIO , OHLENDORF DIETER DR , WINGEN RAINER DR
IPC: G02F1/13 , C07C13/04 , C07C13/28 , C07C22/00 , C07C25/00 , C07C43/184 , C07C43/205 , C07C43/21 , C07C69/92 , C07C255/45 , C07D213/30 , C07D237/08 , C07D237/14 , C07D237/16 , C07D237/18 , C07D239/26 , C07D239/34 , C07D239/38 , C07D241/12 , C07D241/18 , C07D285/12 , C07D285/125 , C07D285/13 , C07D405/12 , C09K19/20 , C09K19/30 , C09K19/34
Abstract: The novel cyclopropylalkyl or -alkenyl compounds have the general formula In this formula, the symbols A , A , A denote unsubstituted and in particular substituted (by halogen or CN) aromatic or heteroaromatic molecular building blocks, such as 1,4-phenylene or pyrimidine-2,5- diyl, which are linked via a single bond or via functional groups M , M , such as CO-O or CH2-O; H and m are zero or 1; j, l, n are zero, 1 or 2. The radicals are R , R , R are H or alkyl/alkenyl, R is alkyl/alkenyl or a substituent known from LC chemistry, such as an alpha - haloalkanoic acid radical. G denotes alkylene or alkenylene.
-
公开(公告)号:DE3909354A1
公开(公告)日:1990-09-27
申请号:DE3909354
申请日:1989-03-22
Applicant: HOECHST AG
Inventor: ESCHER CLAUS DR , DUEBAL HANS-ROLF DR , HARADA TAKAMASA , HEMMERLING WOLFGANG DR , ILLIAN GERHARD DR , MUELLER INGRID DR , MURAKAMI MIKIO , OHLENDORF DIETER DR , WINGEN RAINER DR
Abstract: Ferroelectric liquid crystal systems with high spontaneous polarization, in particular greater than 35 nC cm , and good orientation properties in the ferroelectric phase, in particular, the SC* phase, contain at least three different optically active compounds, preferably dopants in a non-optically active basic mixture which has a nematic phase above the smectic phase. The optically active compounds are chosen so that they do not all induce a helix with an identical direction of rotation in the nematic phase. Their relative concentration is chosen so that the overall resulting pitch of the helix in the total cholesterol phase is not less than 10 mu m.
-
-
-
-
-
-
-
-
-